David A. Anderson

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition.

D. Ferry, Adam J. de Smith, J Malkhandi et al. · PubMed · 1996 · 630 citations

Molecular Pharmacology, Medicinal Chemistry, Urology +14

Evaluation of Fatigue Criteria for Asphalt Binders

David A. Anderson, Yann M. Le Hir, Mihai Marasteanu et al. · Transportation Research Record Journal of the Transportation Research Board · 2001 · 241 citations

Highway Pavement, Engineering, Fatigue Behavior +11

Detection and characterisation of swine hepatitis E virus in New Zealand

Olga Garkavenko, David A. Anderson, H Benard et al. · Journal of Medical Virology · 2001 · 138 citations

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

G Chung-Faye, Daniel H. Palmer, David A. Anderson et al. · PubMed · 2001 · 137 citations

Pharmacokinetic Study, Pathology, Pharmacotherapy +19

Serological evidence for swine hepatitis E virus infection in Australian pig herds

Jenalle D. Chandler, Michaela A. Riddell, Fan Li et al. · Veterinary Microbiology · 1999 · 133 citations

Animal Science, Veterinary Science, Hepatitis +10